Review of common therapeutic options in the United States for the treatment of Pediculosis capitis

Clinical Infectious Diseases

Volumn 36, Issue 11, 2003, Pages 1355-1361

  Jones, Kimberly N ^a   English III, Joseph C ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CROTAMITON; FORMIC ACID; HAIR CLEAN 1 2 3; IVERMECTIN; LEVAMISOLE; LINDANE; MALATHION; PERMETHRIN; PIPERONYL BUTOXIDE; PRONTO; PYRETHRIN; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANEMIA; APLASTIC ANEMIA; BACTERIAL SUPERINFECTION; BLOOD DYSCRASIA; BURNING SENSATION; COCHRANE LIBRARY; CONJUNCTIVITIS; DANDRUFF; DERMATITIS; DIARRHEA; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG RESISTANCE; DRUG SAFETY; DRY SKIN; EDEMA; ERADICATION THERAPY; ERYTHEMA; HUMAN; HYPESTHESIA; INFESTATION; INTOXICATION; META ANALYSIS; NAUSEA; NEUROTOXICITY; PAIN; PEDICULOSIS CAPITIS; PEDICULUS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; PUBLICATION; RASH; RESTLESSNESS; REVIEW; SCALP; SCLERA DISEASE; SEIZURE; SKIN IRRITATION; SOCIAL ASPECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT FAILURE; UNITED STATES; VOMITING;

ANIMALS; HUMANS; INSECTICIDES; IVERMECTIN; LICE INFESTATIONS; LINDANE; MALATHION; PEDICULUS; PERMETHRIN; PYRETHRINS; SCALP DERMATOSES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0038468840     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374840     Document Type: Review

References (71)

1. Meinking T. Infestations. Curr Probl Dermatol 1999; 11:73-120.
2. Burkhart C, Stantiewicz B, Pchalek I, Kruge M, Burkhart C. Molecular composition of the louse sheath. J Parasitol 1999; 85:559-61.
3. Matthieu ME, Wilson BB. Lice (pediculosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:2972-4.
4. Mumcuoglu K, Klause S, Kafka D, Teiler M, Miller J. Clinical observations relating to head louse infestation. J Am Acad Dermatol 1991; 25:248-51.
5. Burkhart C, Burkhart C, Burkhart K. An assessment of topical and oral prescriptions and over-the-counter treatments for head lice. J Am Acad Dermatol 1998; 6:979-82.
6. Witkowski J, Parish L. What's new with the management of head lice. Infect Med 1997; 14:287-9, 296-6.
7. Meinking TL, Taplin D. Infestations. In: Schachner L, Hansen R, eds. Ped dermatol. 2nd ed. New York: Churchill Livingstone, 1995:1347-92.
8. Dodd C. Interventions for treating head lice (Cochrane Review). Cochrane Database Syst Rev 2001;4.
9. Burgess I. Human lice and their management. Adv Parasitol 1995; 36:271-342.
10. Sceck A. "Super lice" force a second look at treatment options. Dermatol Times 1997; 18:3-4.
11. Clore E, Longyear L. Comprehensive pediculosis screening programs for seven elementary schools. J School Health 1990; 60:212-4.
12. Buck M. Treating lice and scabies infestations. Pediatr Pharmacother 1995; 1 (8).
13. Lindane. In: Physicians' desk reference. Montvale, NJ: Medical Economics, 2000:504-5.
14. Maunder J. Resistance to organochloride insecticides in head lice and trials using alternative compounds. Med Officer 1971; 125:27.
15. Blommers L, Van Lennep M. Head lice in the Netherlands: susceptibility for insecticides in field samples. Entomol Exp Appl 1978; 22:243.
16. Blommers L. Insecticidal tests on immature head lice, Pediculus capitis: a new technique. J Med Entomol 1979; 16:82.
17. Taplin D, Meinking T, Castillero P, Sanchez R. Permethrin 1% crime rinse for the treatment of Pediculus humanus vat capitis. Pediatr Dermatol 1986; 3:344-8.
18. Abramowicz M. Drugs for parasitic infections. Med Lett Drugs Ther 1995; 37:99-108.
19. Craig W, Chesney P, Cobbs C, et al. Pyrethrins and piperonyl butoxide. In: Allen L, Ambrosio T, Amerson A, Amidon G, eds. Drug information for the health care professional. Rockville, MD: United States Pharmacopeial Convention, 1998:2458-550.
20. Phipps M. Permethrin: treatment of head lice infestations. Am Pharm 1991; NS31:53-6.
21. Taplin D, Castillero P, Spiegel J, Mercer S, Rivera A, Schachner L. Malathion for the treatment of Pediculus humanus var capitis infestation. JAMA 1982; 247:3103-5.
22. Downs A, Stafford K, Harvey J, Coles G. Evidence for double resistance to permethrin and malathion in head lice. Br J Dermatol 1999; 141:508-11.
23. Ivermectin. In: Physicians' desk reference. Monwale, NJ: Medical Economics, 2000:1886.
24. Burkhart K, Burkhart C, Burkhart C. Update on therapy: ivermectin is available for use against head lice. Infect Med 1997; 14:689.
25. Glaziou P, Nyguyen L, Moulia-Pelat J, Cartel J, Martin P. Efficacy of ivermectin for the treatment of head lice (pediculosis capitis). Trop Med Parasitol 1994; 45:253-4.
26. Friedman S. Lindane neurotoxic reaction in nonbullous congenital ichthyosiform ervthroderma. Arch Dermatol 1987; 123:1056-8.
27. Pollack R, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sample in the United States and Borneo. Arch Pediatr Adolesc Med 1999; 153:969-73.
28. Paller A. Scabies in infants and small children. Semin Dermatol 1993; 12:3-8.
29. Hoke A, Maibach H. Scabies management: a current perspective. Cutis 1999; 64(Suppl):2-14.
30. Burgess I, Peock S, Brown C, Kauffman J. Head lice resistant to pyrethroid insecticides in Britain [letter]. Br Med J 1995; 311:752.
31. Meinking T, Taplin D. Advances in pediculosis, scabies, and other mite infestations. Adv Dermatol 1990; 5:131-52.
32. Hemingway J, Miller J, Mumcuoglu K. Pyrethroid resistance mechanisms in the head louse Pediculus capitis from Israel: implications for control. Med Vet Entomol 1999; 13:89-96.
33. Permethrin. In: Physicians' desk reference. Monwale, NJ: Medical Economics, 2000:497, 767, 3167.
34. Clore E, Longyear L. A comparative study of seven pediculicides and their packaged nit removal combs. J Pediatr Health Care 1993; 7:55450.
35. Meinking T, Taplin D, Kalter D, Eberle M. Comparative efficacy of treatments for pediculosis capitis infestations. Arch Dermatol 1986; 122:261-71.
36. Brandenburg K, Deinard A, DiNapoli J, Englender S, Orthoefu J, Wagner D. 1% Permethrin cream rinse vs. 1% lindane shampoo in treating pediculosis capitis. Am J Dis Child 1986; 140:894-6.
37. Bowerman J, Gomez M, Austin R, Wold D. Comparative study of permethrin 1% cream rinse and lindane shampoo for the treatment of head lice. Pediatr Infect Dis J 1987; 6:252-5.
38. Carlson D, Tribble P, Weart C. Pyrethrin with piperonyl butoxide (RID) vs. 1% permethrin (NIX) in the treatment of head lice. Am J Dis Child 1988; 142:768-9.
39. Dittmann J, Eichler W. Die Kopflaus des Menschen (pediculus capitis). Angew Parasitol 1978; 19:193-7.
40. Burgess I, Brown C, Burgess N. Synergized pyrethrin mousse, a new approach to head lice eradication: efficacy in field and laboratory studies. Clin Ther 1994; 16:57-64.
41. Elston D. What's eating you? Pediculus humanus (head louse and body louse). Cutis 1999; 63:259-64.
42. Meinking T, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol 2002; 138:220-4.
43. Burgess I. Clinical efficacy of treatment for head lice. Br Med J 1995; 311:1369-70.
44. Picollo M, Vassena C, Mougabure Cuerto G, Vernetti M, Zerba E. Resistance to insecticides and effect of synergists on permethrin toxicity in Pediculus capitis (Anoplura: Pediculidae) from Buenos Aires. J Med Entomol 2000; 37:721-5.
45. Mumcuoglu K, Hemingway J, Miller J. Permethrin resistance in the head louse Pediculus capitis from Israel. Med Vet Entomol 1995; 9:427-32, 447.
46. Chosidow O, Chastang C, Brue C, et al. Controlled study of malathion and D-phenothrin for Pediculus humanus var capitis - infested school children. Lancet 1994; 344:1724.
47. Donohue M. Aggressive permethrin therapy beats down lice. Skin Allergy News 1999; September:13.
48. Quarterman M, Lescher J. Neonatal scabies treated with permethrin 5% cream. Pediatr Dermatol 1994; 11:264-6.
49. Permethrin. In: Olin B, ed. Drug facts and comparisons. St Louis, MO: Facts and Comparisons, 1995:584a-6a.
50. Abramowicz M. Malathion for treatment of head lice. Med Lett Drugs Ther 1999; 41:73-4.
51. Malathion. In: Physicians' desk reference. Montvale, NJ: Medical Economics, 2003:1925-6.
52. Meinking T, Entzel P, Villar M, Vicaria M, Lemard G, Porcelain S. Comparative efficacy of treatments for pediculosis capitis infestations. Arch Dermatol 2001; 137:287-92.
53. De Felice J, Wagner D. Head lice outbreaks and their impacts on the community: a public health perspective. In: Proceedings of the World Health Communications Symposium (Fort Lauderdale, FL). Fort Lauderdale, FL: The Symposium, 1985.
54. Ovide [package insert]. Hawthorne, NY: Taro Pharmaceuticals, 1999.
55. Izri M, Briere C. First cases of resistance of Pediculus capitis Linne 1758 to malathion in France [letter]. Presse Med 1995; 24:1444.
56. Silverton N. Malathion resistant pediculosis capitis. Br Med J 1972; 827:646-7.
57. Goldsmid J. Head louse treatment: is there an insecticide resistance problem? Med J Australia 1990; 153:233-4.
58. Banerjee B, Pasha ST, Hussain QZ, et al. A comparative evaluation of immunotoxicity of malathion after subchronic exposure in experimental animals. Indian J Exp Biol 1998; 36:273-82.
59. Contreras H, Bustos-Obregon E. Morphological alterations in mouse testis by a single dose of malathion. J Exp Zool 1999; 284:355.
60. Meinking T, Taplin B, Hermida J, Pardo R, Kerddel F. The treatment of scabies with ivermectin. N Engl J Med 1995; 333:26-30.
61. Brogdon W, McAllister J. Insecticide resistance and vector control. Emerg Infect Dis 1998; 4:605-13.
62. Shashindran C, Gandhi I, Krishnasamy S, Ghosh M. Oral treatment of pediculosis capitis with cotrimoxazole. Br J Dermatol 1978; 98:699.
63. Hipolito R, Mallorca F, Zuniga-Macaraig Z, Apolinario P, Wheeler-Sherman J. Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatr 2001; 107:E30.
64. Abramowicz M. Permethrin for head lice. Med Lett Drugs Ther 1986; 12:89-90.
65. Namazi M. Levamisole: a safe and economical weapon against pediculosis. Int J Dermatol 2001; 40:292-4.
66. National Pediculosis Association. Monoterpenoids and tetralin as pediculosides [letter]. Acta Derm Venereol 1999; 79:1-2. Available at: http: //www.headlice.org/faq/treatments/teatree.htm. Accessed June 2001.
67. Angel T, Nigro J, Levy M. Pediatric dermatology: infestations in the pediatric patient. Pediatr Clin North Am 2000; 47:921-35.
68. De Felice J, Rumsfield J, Bernstein J, Roshal J. Clinical evaluation of an after-pediculicide nit removal system. Int J Dermatol 1989; 28:468-70.
69. Roberts R, Casey D, Morgan D, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet 2000; 356:540-4.
70. Head lice fact sheet. Atlanta, GA: Centers for Disease Control and Prevention, 2001. Available at: http://www.cdc.gov/ncidod/dpd/parasites/ headlice/factsht_head_lice_treating_htm. Accessed June 2001.
71. Pollack R, Kiszewski A, Spielman A. Overdiagnosis and consequent mismanagement of head louse infestations in North America. Pediatr Infect Dis J 2000; 19:689-93.